ProfileGDS5678 / 1434868_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 2% 3% 2% 2% 2% 2% 2% 2% 2% 29% 2% 2% 2% 2% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 11.878842
GSM967853U87-EV human glioblastoma xenograft - Control 21.983833
GSM967854U87-EV human glioblastoma xenograft - Control 31.859532
GSM967855U87-EV human glioblastoma xenograft - Control 41.81422
GSM967856U87-EV human glioblastoma xenograft - Control 51.806712
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 11.902732
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 21.889232
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.838432
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.828892
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.6497529
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.842912
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.83362
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.845712
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.84942